SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001328143-20-000018
Filing Date
2020-04-23
Accepted
2020-04-23 16:03:53
Documents
6
Period of Report
2019-12-31
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A adms2020proxystatement.htm DEF 14A 660691
2 adamas_annualreportxifcxib.jpg GRAPHIC 10345
3 adamas_annualreportxifcxib1.jpg GRAPHIC 10345
4 adamaspharmaceuticalsinc_p.jpg GRAPHIC 217767
5 adamaspharmaceuticalsinc_p1.jpg GRAPHIC 5742241
6 proxyadmslogo1.jpg GRAPHIC 3700
  Complete submission text file 0001328143-20-000018.txt   8890195
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 20811033
SIC: 2834 Pharmaceutical Preparations